Doerge D R, Divi R L, Deck J, Taurog A
Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas 72079-9502, USA.
Chem Res Toxicol. 1997 Jan;10(1):49-58. doi: 10.1021/tx960150g.
Administration of minocycline (MN), a tetracycline antibiotic, produces a black pigment in the thyroids of humans and several species of experimental animals and antithyroid effects in rodents. We have previously shown that these effects appear to be related to interactions of MN with thyroid peroxidase (TPO), the key enzyme in thyroid hormone synthesis. In the present study, the mechanisms for inhibition of TPO-catalyzed iodination and coupling reactions by MN were investigated. MN was stable in the presence of TPO and H2O2, but adding iodide or a phenolic cosubstrate caused rapid conversion to several products. TPO-dependent product formation, characterized by on-line LC-APCI/MS and 1H-NMR, involved oxidative elimination to form the corresponding benzoquinone with subsequent dehydrogenation at the aliphatic 4-(dimethylamino) group. Addition of thiol-containing polymers (bovine serum albumin or thiol-agarose chromatographic beads) had a minimal effect on MN oxidation by TPO, but substantially reduced product formation and produced concomitant losses in free thiols. Covalent bonding through a thioether linkage of a reactive intermediate, the benzoquinone iminium ion, was inferred from these findings. Iodide- and phenolic cosubstrate-dependent oxidation of tetracycline to demethylated and dehydrogenated products was also observed, although at a slower rate than MN. The products and kinetics observed with MN were consistent with oxidation of MN by either the enzymatic iodinating species formed by reaction of TPO compound I with iodide or phenoxyl radicals/cations generated by TPO-mediated oxidation of a phenolic cosubstrate. The proposed reaction mechanism is consistent with alternate substrate inhibition of TPO-catalyzed iodination of tyrosyl residues in thyroglobulin (Tg) by MN, as previously reported. Furthermore, the observed phenoxyl radical-mediated oxidation of MN is consistent with its previously reported potent inhibition of the coupling of hormonogenic iodotyrosine residues in Tg in the reaction that forms thyroid hormones. The proposed reaction mechanism also implicates a reactive benzoquinone iminium ion intermediate that could be important in toxicity of MN.
米诺环素(MN)是一种四环素类抗生素,在人类和几种实验动物的甲状腺中会产生黑色色素,并对啮齿动物产生抗甲状腺作用。我们之前已经表明,这些作用似乎与MN和甲状腺过氧化物酶(TPO)(甲状腺激素合成中的关键酶)的相互作用有关。在本研究中,我们研究了MN抑制TPO催化的碘化和偶联反应的机制。MN在TPO和H2O2存在下是稳定的,但加入碘化物或酚类共底物会导致其迅速转化为几种产物。通过在线LC-APCI/MS和1H-NMR表征的TPO依赖性产物形成涉及氧化消除以形成相应的苯醌,并随后在脂肪族4-(二甲氨基)基团处脱氢。添加含硫醇的聚合物(牛血清白蛋白或硫醇琼脂糖色谱珠)对TPO氧化MN的影响最小,但显著减少了产物形成,并导致游离硫醇同时损失。从这些发现中推断,通过反应性中间体苯醌亚胺离子的硫醚键进行共价键合。还观察到碘化物和酚类共底物依赖性地将四环素氧化为去甲基化和脱氢产物,尽管其速率比MN慢。用MN观察到的产物和动力学与MN被TPO化合物I与碘化物反应形成的酶促碘化物种或TPO介导的酚类共底物氧化产生的苯氧基自由基/阳离子氧化一致。所提出的反应机制与之前报道的MN对甲状腺球蛋白(Tg)中酪氨酸残基的TPO催化碘化的替代底物抑制一致。此外,观察到的苯氧基自由基介导的MN氧化与其之前报道的对形成甲状腺激素的反应中Tg中激素生成碘酪氨酸残基偶联的有效抑制一致。所提出的反应机制还涉及一个反应性苯醌亚胺离子中间体,这可能在MN的毒性中起重要作用。